mFLUSIVA
NDC 80777-500, Influenza Vaccine, mRNA, injection, suspension, from Moderna US, Inc..
- Product NDC
- 80777-500
- Status
- Listed
- Labeler
- Moderna US, Inc.
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125869
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80777-500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RNA-101-BFL312.5 ug/.38mL
- RNA-101-BFL612.5 ug/.38mL
- RNA-101-BFL512.5 ug/.38mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80777-500-20 | 80777050020 | 10 SYRINGE, PLASTIC in 1 CARTON (80777-500-20) / .38 mL in 1 SYRINGE, PLASTIC (80777-500-18) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 80777-500 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80777-500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80777-500. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.